Joseph Mikhael, MD
Hematology · Scottsdale, AZNPI 1972781581
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $982,403 of the $1,504,411 with a category attached, or 65.3%. 28 manufacturers reported payments, led by Pfizer at 42.3% of the total.
Across 437 payments — averaging $3442.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$636K
- Sanofi$155K
- Amgen$143K
- Sanofi-aventis U.S. LLC$129K
- Karyopharm Therapeutics Inc.$120K
- Bristol Myers Squibb$58K
- plus $262K from 22 others
Across 130 payments — averaging $8601.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$383K
- Sanofi US Services Inc.$267K
- AbbVie$242K
- Janssen Research & Development, LLC$88K
- Pharmacyclics LLC, An Abbvie Company$54K
- Regeneron$20K
- plus $64K from 8 others
What the payments were for
- Consulting fees$982,40365%
- Speaking & faculty fees$460,02531%
- Travel & lodging$47,7793%
- Food & beverage$5,9310%
- Education$8,2741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 34 | $636,275 |
| Sanofi | 75 | $154,940 |
| Amgen | 48 | $143,404 |
| Sanofi-aventis U.S. LLC | 36 | $129,357 |
| Karyopharm Therapeutics Inc. | 68 | $120,192 |
| Bristol Myers Squibb | 39 | $57,803 |
| Janssen Research & Development, LLC | 3 | $55,650 |
| Johnson & Johnson | 37 | $52,599 |
| GSK | 20 | $39,379 |
| E.r. Squibb & Sons, L.L.C. | 17 | $35,457 |
| Stemline Therapeutics Inc. | 4 | $20,333 |
| Janssen Global Services, LLC | 6 | $17,850 |
| AbbVie | 8 | $11,048 |
| Hexal AG | 4 | $6,059 |
| Genentech USA, Inc. | 4 | $5,086 |
| Dr.reddy's Laboratories,inc. | 4 | $4,000 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $3,375 |
| Astrazeneca UK Limited | 2 | $2,800 |
| Sanofi US Services Inc. | 2 | $2,534 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $2,433 |
| Sebia Inc | 1 | $2,000 |
| The Binding Site Inc. | 8 | $1,429 |
| TG Therapeutics, Inc. | 1 | $120 |
| Regeneron | 1 | $108 |
| Pharming Healthcare, Inc. | 1 | $88 |
| Secura Bio, Inc. | 2 | $40 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
| Genentech, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few hematology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Scottsdale
- Rafael FonsecaScottsdale$650K
- Pierre NoelScottsdale$51K
- Abdullah LadhaScottsdale$17K
- John PawloskiPhoenix$246K
- Danielle NanceGilbert$86K
- Misam ZawitGoodyear$11K
- Abdulrahman AbonofalGoodyear$1K
- Pedro Camacho MaldonadoGilbert$469
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.